ESC 365 - Antithrombotic therapy improves long-term prognosis in patients with atrial fibrillation and heart failure -A report from the CHART-2 Study-

HFA Premium Access

Antithrombotic therapy improves long-term prognosis in patients with atrial fibrillation and heart failure -A report from the CHART-2 Study-

Session: Poster Session 4 - Atrial Fibrillation - Epidemiology, Prognosis, Outcome

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor T. Shiroto (Sendai, JP)

Event: Heart Failure 2018

Congress Presentation

About the speaker

Doctor Takashi Shiroto

Tohoku University, Sendai (Japan)

0 follower

2 more presentations in this session

Heart failure in patients with non-valvular atrial fibrillation. Insight from the national observational cross-sectional registry.

Speaker: Doctor L. Urban (Bratislava, SK)

Relevance of device detected atrial arrhythmias in patients with cardiac implantable electronic devices (CIEDs) in a real world scenario.

Speaker: Doctor S. Sasidharan (kottarakkara, IN)

Access the full session

Poster Session 4 - Atrial Fibrillation - Epidemiology, Prognosis, Outcome

Speakers: Doctor T. Shiroto, Doctor L. Urban, Doctor S. Sasidharan

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by